Recursion Pharmaceuticals, Inc. (RXRX)
3.245
-0.26
(-7.29%)
USD |
NASDAQ |
Aug 24, 16:00
3.26
+0.02
(+0.46%)
After-Hours: 20:00
Recursion Pharmaceuticals Total Liabilities (Quarterly) : 297.66M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 297.66M |
| March 31, 2026 | 314.75M |
| December 31, 2025 | 397.49M |
| September 30, 2025 | 352.58M |
| June 30, 2025 | 383.21M |
| March 31, 2025 | 371.29M |
| December 31, 2024 | 413.82M |
| September 30, 2024 | 201.94M |
| June 30, 2024 | 191.41M |
| March 31, 2024 | 156.70M |
| December 31, 2023 | 190.26M |
| September 30, 2023 | 192.86M |
| Date | Value |
|---|---|
| June 30, 2023 | 197.74M |
| March 31, 2023 | 197.19M |
| December 31, 2022 | 215.48M |
| September 30, 2022 | 223.50M |
| June 30, 2022 | 234.94M |
| March 31, 2022 | 240.75M |
| December 31, 2021 | 67.41M |
| September 30, 2021 | 59.57M |
| June 30, 2021 | 55.88M |
| March 31, 2021 | 56.66M |
| December 31, 2020 | 56.56M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Twist Bioscience Corp. | 226.70M |
| Absci Corp. | 22.79M |
| Novavax, Inc. | 1.146B |
| Editas Medicine, Inc. | 132.08M |
| Dyne Therapeutics, Inc. | 291.86M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.213B |
| Shareholders Equity (Quarterly) | 915.00M |
| Debt to Equity Ratio | 0.0728 |
| Current Ratio | 5.034 |
| Net Debt Paydown Yield | 0.27% |